CARA THERAPEUTICS INC shareholders Q2 2023

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 138 filers reported holding CARA THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.09 and the average weighting 0.0%.

CARA THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Chescapmanager LLC 1,655,576$4,685,2800.73%
Bain Capital Life Sciences Investors, LLC 934,898$2,645,7610.27%
FNY Investment Advisers, LLC 35,000$990.12%
DISCIPLINED GROWTH INVESTORS INC /MN 1,764,201$4,992,6890.11%
Ergoteles LLC 358,275$1,013,9180.05%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 84,530$239,2200.04%
PDT Partners, LLC 85,088$240,7990.03%
PINNACLE ASSOCIATES LTD 672,440$1,903,0050.03%
Alpine Global Management, LLC 34,014$96,2600.03%
XTX Topco Ltd 52,025$147,2310.03%
FARALLON CAPITAL MANAGEMENT LLC 1,666,591$4,716,4530.02%
GSA CAPITAL PARTNERS LLP 81,688$2310.02%
C WorldWide Group Holding A/S 583,460$1,6510.02%
Woodline Partners LP 631,351$1,786,7230.02%
Vident Investment Advisory, LLC 194,262$549,7610.02%
JACOBS LEVY EQUITY MANAGEMENT, INC 1,022,882$2,894,7560.02%
Cypress Capital Management LLC (WY) 5,350$15,1410.02%
Verition Fund Management LLC 450,000$1,273,5000.02%
Intrepid Financial Planning Group LLC 11,500$32,5450.02%
B. Riley Wealth Advisors, Inc. 154,990$438,6220.01%
External links

This page lists CARA THERAPEUTICS INC's shareholders in Q2 2023. To view CARA THERAPEUTICS INC's shareholder history, click here.